Aardvark Therapeutics, Inc.
AARD
$8.22
-$0.30-3.52%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | ||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 637.44% | -- | -- | -- | |
| Total Receivables | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | |
| Prepaid Expenses | 24.60% | -- | -- | -- | |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | |
| Other Current Assets | 25.98% | -- | -- | -- | |
| Total Current Assets | 615.06% | -- | -- | -- | |
|
|
|||||
| Total Current Assets | 615.06% | -- | -- | -- | |
| Net Property, Plant & Equipment | 374.19% | -- | -- | -- | |
| Long-term Investments | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | |
| Total Other Intangibles | -- | -- | -- | -- | |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | |
| Total Other Assets | 20,169.23% | -- | -- | -- | |
| Total Assets | 635.64% | -- | -- | -- | |
|
|
|||||
| Total Accounts Payable | 122.03% | -- | -- | -- | |
| Total Accrued Expenses | 874.89% | -- | -- | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Current | 201.79% | -- | -- | -- | |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | |
| Total Other Current Liabilities | -- | -- | -- | -- | |
| Total Current Liabilities | 256.51% | -- | -- | -- | |
|
|
|||||
| Total Current Liabilities | 256.51% | -- | -- | -- | |
| Long-Term Debt | -- | -- | -- | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Capital Leases | 782.00% | -- | -- | -- | |
| Finance Division Debt Non Current | -- | -- | -- | -- | |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | |
| Total Other Liabilities | 1,200.00% | -- | -- | -- | |
| Total Liabilities | 276.15% | -- | -- | -- | |
|
|
|||||
| Common Stock & APIC | 25.43% | -- | -- | -- | |
| Retained Earnings | -54.55% | -- | -- | -- | |
| Treasury Stock & Other | -- | -- | -- | -- | |
| Total Common Equity | -57.01% | -- | -- | -- | |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | |
| Preferred Stock Convertible | 188.71% | -- | -- | -- | |
| Preferred Stock, Others | -- | -- | -- | -- | |
| Total Preferred Equity | 188.71% | -- | -- | -- | |
|
|
|||||
| Total Common Equity | -57.01% | -- | -- | -- | |
| Total Preferred Equity | 188.71% | -- | -- | -- | |
| Total Minority Interest | -- | -- | -- | -- | |
| Total Equity | 692.28% | -- | -- | -- | |
|
|
|||||